TRANSVERCID 14.54 mg/12 mm, application device cutaneous sachet
Active ingredients: Salicylic acid
Commercialized according to BDPM
Application devicesachetcutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TRANSVERCID 14,54 mg/12 mm, dispositif pour application cutanée
- Pharmaceutical form
- dispositif pour application
- Route of administration
- cutanée
- Presentation description
- 1 sachet(s) papier polyéthylène aluminium de 8 dispositif(s) avec 10 sparadraps
- Marketing authorisation holder
- PIERRE FABRE MEDICAMENT
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 May 2024
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62345455CIP73487333CIP133400934873331Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACIDE SALICYLIQUEdispositif | 14,54 mg · un dispositif | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.